Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.8.0.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Revenue:    
Product revenues $ 0 $ 0
License revenues 0 0
TOTAL REVENUE 0 0
Cost of Product Revenue 0 0
Gross profit 0 0
Operating Expenses:    
Research and development 1,068,000 975,000
Selling, general and administrative 134,502,000 8,399,000
Total operating expenses 135,570,000 9,374,000
Loss from Operations (135,570,000) (9,374,000)
Change in value of warrant and derivative liabilities 925,000 25,697,000
Interest expense/income (8,602,000) (6,555,000)
Total Other Income (Expense) (7,677,000) 19,142,000
Income (loss) before minority interest and provision for income taxes (143,247,000) 9,768,000
Less: Net loss attributable to the noncontrolling interests 0 0
Income (loss) before provision for income taxes (143,247,000) 9,768,000
Provision for income taxes 0 0
Net loss $ (143,247,000) $ 9,768,000
Weighted average shares outstanding    
Basic 16,769,431 81,460
Diluted 16,769,431 81,460
Net income (loss) per share    
Basic $ (8.54) $ 119.91
Diluted $ (8.54) $ 119.91